ANN ARBOR - The University of Michigan has named its bipolar disorder research program for Heinz Prechter, in honor of a new gift commitment of up to $5 million by the World Heritage Foundation - Prechter Family Fund. But the gift comes with a challenge to others who care about bipolar disorder: The Prechter family
ANN ARBOR - Genomenon announced a $1.8 milion grant awarded by the National Institutes of Health will fund Genomenon’s further innovation in genomic analysis, streamlining the literature research and curation process leading to faster patient diagnosis. “This grant recognizes the solid approach and great potential of Genomenon’s technology to drive rapid improvements in automating accurate gene
ANN ARBOR - Enzo Life Sciences has released its newest immunohistochemistry product, MULTIVIEW® PLUS (mouse-HRP/rabbit-AP) IHC Kit (Brown/Green). This non-biotin nanopolymer detection system contains reagents and materials that detect and localize antigens in formalin-fixed paraffin-embedded tissues. The new MULTIVIEW PLUS IHC kit optimizes your IHC process by including the entire workflow, from antigen retrieval to
ANN ARBOR - ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, Tuesday announced new appointments and promotions involving the company’s board of directors and management team. The company has appointed Christine (Chris) Gibbons as a new, independent member of its board of directors, replacing departing
NEW YORK - Cancer is caused by mistakes in DNA, and a new study finds that in most cancer cases, these mistakes are completely random; they're not due to heredity or environmental factors, but rather the result of random errors. The mistakes, or mutations, cause cancer to happen because even a tiny error in DNA
ANN ARBOR - Thin parts of the cell membranes of neurons turn out to be particularly vulnerable to a protein that collects in the brain of people with Alzheimer's disease, according to a University of Michigan researcher. The discovery could open an avenue for developing treatments for Alzheimer's disease that work within the cell's membrane.
ANN ARBOR - A new interdisciplinary health sciences resource center at the University of Michigan has received an $11.7 million award from the National Institutes of Health to advance regenerative medicine. The center, led by the School of Dentistry, brings together scientists, engineers and clinicians from several U-M departments in collaboration with researchers at the
ANN ARBOR - Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company, announced that it has closed on the sale of 1.3 million shares of stock to a select group of accredited investors that will raise about $12.5 million, providing cash flow through 2018. Gemphire Therapeutics will use the money to fund development costs, the company said
ANN ARBOR - A University of Michigan startup that's developing a non-invasive way to remove diseased tissue from cancer patients using high-intensity ultrasound has attracted $8.3 million in Series B financing. The investment will help advance clinical trials of HistoSonics' Robotic Assisted Sonic Therapy—an innovative tissue-destruction technology targeted for liver cancer and other solid tumor
ANN ARBOR - States that participated in Medicaid expansion under the Affordable Care Act saw increased insurance rates and access to care, less worry about paying medical bills, but also longer wait times among low-income residents, according to new research. In a study published in the New England Journal of Medicine, Sarah Miller of the
